HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$30.73
Day range
$30.74 - $32.01
Year range
$26.74 - $46.00
Market cap
2.43B USD
Avg Volume
1.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.50M | — |
Operating expense | 19.04M | 28.71% |
Net income | -65.05M | -35.71% |
Net profit margin | -867.29 | — |
Earnings per share | -0.83 | -33.87% |
EBITDA | -72.08M | -23.31% |
Effective tax rate | -0.66% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 549.63M | -21.44% |
Total assets | 743.28M | -19.12% |
Total liabilities | 39.32M | 25.53% |
Total equity | 703.96M | — |
Shares outstanding | 76.73M | — |
Price to book | 3.34 | — |
Return on assets | -23.59% | — |
Return on capital | -24.63% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -65.05M | -35.71% |
Cash from operations | -61.65M | -33.48% |
Cash from investing | 34.51M | 179.90% |
Cash from financing | 1.15M | — |
Net change in cash | -26.06M | 70.97% |
Free cash flow | -43.79M | -33.12% |
About
Founded
1996
Headquarters
Website
Employees
322
